Legionnaires' disease: evaluation of a quantitative microbial risk assessment model

Thomas W Armstrong1, Charles N Haas

  • 1ExxonMobil Biomedical Sciences, Inc., Annandale, NJ 08801-0971, USA. twa8hr@gmail.com

Abstract

Related Concept Videos